Main Article Content
Abstract
Background: Diabetic foot ulcer is one of the most significant and devastating complications of diabetes, and is defined as a foot affected by ulceration that is associated with neuropathy and/or peripheral arterial disease of the lower limb in a patient with diabetes. The global diabetic foot ulcer Prevalence was 6.3% which was higher in males than in females and higher in t2dm than in t1dm.
Aims And Objectives: To determine the prevalence, drug prescribing patterns, severity of diabetic foot ulcer and to assess the anxiety and depression using HADS scale in type 2 diabetes patients.
Materials And Methodology: A Prospective observational study with a sample size of 130 patients in a period of 6 months was conducted as per inclusion and exclusion criteria. Clinical data is collected from patients who are diagnosed with diabetic foot ulcer and received anti-diabetic medications.
Results: According to our study males 76.0% ( 99)were more prevalant than females 24.0% (31). Majority of patient were on 127(97.7%)Insulin treatment and 19 were on oral hypoglycaemic treatment and 115 (88.5%)Beta lactamase inhibitors, 113 (86.9%)cephalosporins and 73(56.2%)macrolides were highly prescribed . Majority of patients were in grade - 3 41.5% (54) severity of DFU . Anxiety 28 (21.5%)was majorly observed when compared to the Depression 14 (10.8%) according to HADS scale .
Conclusion: Foot ulcers in patients with diabetes is common, and frequently leads to lower limb amputation unless a prompt, rational, multidisciplinary approach to therapy is taken. The health care providers are recommended to enhance preventive measures in the reduction of foot ulcer through promoting foot self-care practice, giving special emphasis during follow-up of patients who came from rural areas, educating the patient to reduce overweight gain, and managing the neuropathy thoroughly in order to decrease the occurrence of diabetic foot ulcer.